DEA Proposes New Import, Export Restrictions for Amineptine
The Drug Enforcement Administration is proposing to list amineptine, a synthetic tricyclic antidepressant with central nervous system (CNS) stimulating properties that, according to the Department of Health and Human Services, has no approved medical use and no known therapeutic application…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
in the U.S., under schedule I of the Controlled Substances Act, it said in a notice released July 21. "If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, amineptine." Comments are due Sept. 20.